companydata.dkNordisk Selskab for Gynækologisk Onkologis Kliniske Forskningsfond: Financial statements 2025
CVR: 30197372
Nordisk Selskab for Gynækologisk Onkologis Kliniske Forskningsfond (CVR 30197372) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 7,463,032 and a net result of DKK -334,181 compared with DKK 1,408,745 the year before. That is an increase of 6.1% compared with the year before. Equity amounted to DKK 4,906,927. The solvency ratio was 17.5%. The company had 15 employees in the financial year.
- Gross Profit
- 7,463,032 kr.
- Profit/Loss
- -334,181 kr.
- Equity
- 4,906,927 kr.
- Total Assets
- 27,970,798 kr.
- Employees
- 15
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 7.5 mio. | -334 t. | 4.9 mio. | 15 |
| 2024 | - | 7 mio. | 1.4 mio. | 5.2 mio. | 12 |
| 2023 | - | 7.1 mio. | 1.1 mio. | 3.8 mio. | 12 |
| 2022 | - | 7.4 mio. | 467 t. | 2.7 mio. | 12 |
| 2021 | - | 4.6 mio. | -631 t. | 2.3 mio. | 10 |
Find more companies like Nordisk Selskab for Gynækologisk Onkologis Kliniske Forskningsfond
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
Nordisk Selskab for Gynækologisk Onkologis Kliniske Forskningsfond has published its annual report for 2024. Gross profit came to DKK 7,031,626, and the net result was DKK 1,408,745.
As of April 14, 2025, Kristine Madsen is registered as director of Nordisk Selskab for Gynækologisk Onkologis Kliniske Forskningsfond.
As of April 14, 2025, Mansoor Raza Mirza has stepped down as director of Nordisk Selskab for Gynækologisk Onkologis Kliniske Forskningsfond.
About Nordisk Selskab for Gynækologisk Onkologis Kliniske Forskningsfond
Nordisk Selskab for Gynækologisk Onkologis Kliniske Forskningsfond is a Danish company of the type Erhvervsdrivende fond based in København Ø, founded in 2006. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Kristine Madsen. The company has 2 employees. In 2025, the company reported a gross profit of DKK 7,463,032 and a net result of DKK -334,181 compared with DKK 1,408,745 the year before. Equity amounted to DKK 4,906,927.